Purchases and Sales Made in Q3 2022 in Eli Lilly & CO (LLY)
This table provides information about the institutional ownership of Eli Lilly & CO (LLY) during Q3 2022. The information is specifically focused on institutions that hold shares of ELI LILLY & Co.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-737K- 4.75% |
$218M - $249M
|
14.8M
$11.8B
|
|
Nov 14, 2022
Q3 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-979K- 13.45% |
$290M - $331M
|
6.3M
$5.04B
|
|
Nov 15, 2022
Q3 2022
|
Verity Asset Management, Inc.
Durham, NC |
SELL
|
- |
-1.05M- 99.94% |
$310M - $354M
|
672
$537K
|
|
Nov 14, 2022
Q3 2022
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-1.09M- 30.43% |
$322M - $367M
|
2.48M
$1.99B
|
|
Nov 08, 2022
Q3 2022
|
Allianz Asset Management Gmb H
Munich, 2M |
SELL
|
- |
-1.36M- 70.94% |
$403M - $460M
|
557K
$446M
|
|
Nov 14, 2022
Q3 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.59M- 6.8% |
$473M - $539M
|
21.8M
$17.5B
|
|
Nov 08, 2022
Q3 2022
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
SELL
|
- |
-2.03M- 34.23% |
$602M - $686M
|
3.9M
$3.12B
|